Sunday, June 25, 2017

Jury Selection to Begin in Martin Shkreli Trial

Federal prosecutors allege that the former Turing Pharmaceuticals CEO committed a series of interconnected frauds, misleading investors in his hedge funds and looting a publicly traded pharmaceutical company to cover the losses.

from WSJ.com: US Business http://ift.tt/2sFRLPb
via IFTTT

No comments:

Post a Comment